Abbot Financial Management, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Abbot Financial Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $17,219 - $21,729	-30 Reduced 8.17%	337 $232,000
Q4 2021 Feb 15, 2022	SELL	$543.48 - $670.97 $214,131 - $264,362	-394 Reduced 51.77%	367 $232,000
Q2 2021 Aug 05, 2021	BUY	$472.8 - $558.54 $23,640 - $27,927	50 Added 7.03%	761 $425,000
Q1 2021 May 13, 2021	BUY	$446.73 - $548.2 $64,775 - $79,489	145 Added 25.62%	711 $336,000
Q4 2020 Feb 11, 2021	BUY	$478.3 - $607.98 $270,717 - $344,116	566 New	566 $273,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Abbot Financial Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Abbot Financial Management, Inc. with notifications on news.